The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
Research on CAR T cells has achieved enormous progress in recent years. After the impressive results obtained in relapsed and refractory B-cell acute lymphoblastic leukemia and aggressive B-cell lymphomas, two constructs, tisagenlecleucel and axicabtagene ciloleucel, were approved by FDA. The role o...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Revisão |
| 言語: | 英語 |
| 出版事項: |
2020
|
| オンライン･アクセス: | https://doi.org/10.3389/fimmu.2020.00888 https://www.frontiersin.org/articles/10.3389/fimmu.2020.00888/pdf |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|